| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/1999 | CN1214677A Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 04/21/1999 | CN1214675A Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 04/21/1999 | CN1214672A Dimethyl-substituted cyclohexane diene derivatives |
| 04/21/1999 | CN1214636A Photpheresis treatment of chronic HCV infections |
| 04/21/1999 | CN1214634A Antipruritic agent |
| 04/21/1999 | CN1214631A Use of rapamycin derivatives in vasculopathies and xenotransplantation |
| 04/21/1999 | CN1214630A Photopheresis treatment of leukocytes |
| 04/21/1999 | CN1214629A Solid instant-release forms of administration and process for producing the same |
| 04/21/1999 | CN1214624A Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
| 04/21/1999 | CN1214616A Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acid |
| 04/21/1999 | CN1214365A Health care wine |
| 04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
| 04/21/1999 | CN1214264A Sulfanilamide derivative for diagnosis and treatment of tumor and its preparation |
| 04/21/1999 | CN1214257A Chinese medicine for curing gastric cancer and esophagus cancer |
| 04/21/1999 | CN1214246A Composite antiseptic medicine |
| 04/21/1999 | CN1214245A Application of sinomenine in preparing analgesic |
| 04/21/1999 | CN1214244A Use of rifaximin and of pharmaceutical compositions containing it in treatment of diarrhoea from cryptosporidiosis |
| 04/21/1999 | CN1043045C Oligonucleotide capable of inhibiting endothelin generation |
| 04/21/1999 | CN1043043C Preparation of crystalline cephem acid addition salt |
| 04/21/1999 | CN1043042C Resolution method of alpha-(2,2-dimethylpropionyloxy) ethyl 7-[2-(2-amino-thiazol-4-yl)-2-(2)-hydroxyl-imino-acetamido]-3-(methoxy methyl)-3-cephem-4-carboxylate |
| 04/21/1999 | CN1043011C Oral anthelmintic tablet |
| 04/21/1999 | CA2251266A1 Beta-ketoester |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895789 Salt forms of ketoprofen, ibuprofen, naproxen, and tiaprofenic acid for injections; antiinflammatory agents, analgesics |
| 04/20/1999 | US5895788 Ascites in poultry |
| 04/20/1999 | US5895787 Treatment of fibromyalgia and related disorders |
| 04/20/1999 | US5895786 Method for treating viral infections |
| 04/20/1999 | US5895785 Treatment and prevention of disorders mediated by LA-paf or endothelial cells |
| 04/20/1999 | US5895784 Treatment with antimetastasis and antitumor agents |
| 04/20/1999 | US5895783 Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
| 04/20/1999 | US5895663 Pseudoephedrine hydrochloride extended-release tablets |
| 04/20/1999 | US5895660 Deuterated active substances in transdermal application |
| 04/20/1999 | US5895658 Sustained release of nitric oxide to treat effects of diabetes, stimulate hair growth and heal wounds |
| 04/20/1999 | US5895656 Gas or gel-filled silicone cushion for treatment of keloid and hypertrophic scars |
| 04/20/1999 | US5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists |
| 04/20/1999 | US5895642 Pseudocatalase activity |
| 04/20/1999 | US5895370 Medical probe (with stylets) device |
| 04/20/1999 | CA2250664A1 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 04/20/1999 | CA2214895C Improved pharmaceutical composition comprising fenofibrate |
| 04/20/1999 | CA2165806C Antiparasitic agents |
| 04/20/1999 | CA2138447C Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation |
| 04/20/1999 | CA2124990C Pharmaceutical agents for treatment of emesis |
| 04/20/1999 | CA2120290C Process for preparing spherules of active agents |
| 04/20/1999 | CA2116524C Antiphlogistic analgesic plastic |
| 04/20/1999 | CA2113229C Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof |
| 04/17/1999 | WO1999020257A1 Hormone replacement therapy drug formulations for topical application to the skin |
| 04/17/1999 | CA2250523A1 Dithiolylidene acetamide derivatives |
| 04/16/1999 | CA2250341A1 Epichlorohydrin and 1-(3-aminopropyl) imidazole copolymer and its use in treating irritable bowel syndrome |
| 04/15/1999 | WO1999018235A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
| 04/15/1999 | WO1999018215A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018195A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018142A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999018107A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/15/1999 | WO1999018105A1 Dipyridoimidazolderivatives useful in treating central nervous system disorders |
| 04/15/1999 | WO1999018104A1 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders |
| 04/15/1999 | WO1999018101A1 Benzothiophenes |
| 04/15/1999 | WO1999018099A1 Aryl thiophene derivatives as pde iv inhibitors |
| 04/15/1999 | WO1999018097A1 Crystalline antifungal polymorph |
| 04/15/1999 | WO1999018096A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | WO1999018095A1 Aryl furan derivatives as pde iv inhibitors |
| 04/15/1999 | WO1999018091A1 Novel compounds useful as neuro-protective agents |
| 04/15/1999 | WO1999018090A1 An efficient method for the conversion of nitriles to amidines |
| 04/15/1999 | WO1999018084A1 Method and reagents for n-alkylating ureides |
| 04/15/1999 | WO1999018083A1 N,n'-(sulphonyldi-1, 4-phenylen) bis (n'',n''- dimethylformamidin)-1, 2,3,4-tetrahydro- 6-methyl-2, 4-dioxo-5-pyrimidinsulphonate for stimulating cellular metabolism and having an immunotropic and anti-bacterial activity and method for producing the same |
| 04/15/1999 | WO1999018081A1 Substituted fused heterocyclic compounds |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018075A1 Novel dihydronaphthalene compounds and process for producing the same |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999018073A1 Azetidinone derivatives for the treatment of hcmv infections |
| 04/15/1999 | WO1999018072A1 Azetidinone derivatives for the treatment of hcmv infections |
| 04/15/1999 | WO1999018071A1 Azetidinone derivatives for the treatment of hcmv infections |
| 04/15/1999 | WO1999018070A1 Novel vitamin d analogues |
| 04/15/1999 | WO1999018068A1 Styryl sulfone anticancer agents |
| 04/15/1999 | WO1999018066A1 Amidocarboxylic acid derivatives |
| 04/15/1999 | WO1999017804A1 Polymeric derivatives of camptothecins |
| 04/15/1999 | WO1999017803A1 Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 04/15/1999 | WO1999017802A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017784A1 Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| 04/15/1999 | WO1999017782A1 Composition for treatment of diabetes and treatment of diabetes |
| 04/15/1999 | WO1999017781A1 Osteoblast-specific mitogens and drugs containing such compounds |
| 04/15/1999 | WO1999017780A1 Dexamethasone gel |
| 04/15/1999 | WO1999017779A1 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 04/15/1999 | WO1999017777A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | WO1999017776A1 Novel cycloalkenyl substituted compounds |
| 04/15/1999 | WO1999017775A1 QUINOLINE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017774A1 Product and method for the treatment of hyperlipidemia |
| 04/15/1999 | WO1999017773A1 Compounds and methods |
| 04/15/1999 | WO1999017772A1 5ht4 agonists and antagonists |
| 04/15/1999 | WO1999017771A1 Granular preparations of 5-(2-ethyl- 2h-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine |
| 04/15/1999 | WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity |
| 04/15/1999 | WO1999017769A1 INDENO[1,2-c]-, NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES |
| 04/15/1999 | WO1999017768A1 Treatment of fibromyalgia and related disorders |
| 04/15/1999 | WO1999017767A1 Methods of treating and preventing endometriosis with phytoestrogens |
| 04/15/1999 | WO1999017766A1 Compressed nitroglycerin tablet and its method of manufacture |